CTOs on the Move

Diagnostic Centers of America

www.dcamedical.com

 
Diagnostic Centers of America is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dcamedical.com
  • 6290 Linton Blvd Ste 101
    Delray Beach, FL USA 33484
  • Phone: 561.994.8600

Executives

Name Title Contact Details

Similar Companies

Tallahassee Memorial HealthCare

Tallahassee Memorial HealthCare is a private, not-for-profit community healthcare system founded in 1948.

Ahura Scientific

Ahura Scientific is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Boyds Pharmacy

Boyds Pharmacy is a Florence, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Noridian Healthcare Solutions

Noridian Healthcare Solutions, LLC (Noridian) develops solutions for federal, state and commercial health care programs through a full suite of innovative offerings, including claims processing, medical review, and contact center and provider administrative services. Headquartered in Fargo, N.D. with staff located throughout the nation, Noridian administrates people-first services across all 50 U.S. states. Leveraging its decades of experience, the Noridian team designs and implements customizable, high-quality solutions to eliminate common health care barriers, enabling access to care.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.